tiprankstipranks
Trending News
More News >
BioLineRX Ltd. (IL:BLRX)
:BLRX
Israel Market

Bioline Rx (BLRX) Financial Statements

Compare
2 Followers

Bioline Rx Financial Overview

Bioline Rx's market cap is currently 69.06M. The company's EPS TTM is ; its P/E ratio is ―; Bioline Rx is scheduled to report earnings on May 27, 2025, and the estimated EPS forecast is -0.35. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 28.94M$ 4.80M$ 0.00$ 0.00$ 0.00
Gross Profit$ 19.68M$ 1.11M$ 0.00$ 0.00$ 0.00
Operating Income$ -20.41M$ -49.69M$ -29.16M$ -24.78M$ -22.93M
EBITDA$ 3.92M$ -57.09M$ -28.50M$ -24.07M$ -22.34M
Net Income$ -9.22M$ -60.61M$ -20.75M$ -28.14M$ -30.93M
Balance Sheet
Cash & Short-Term Investments$ 19.56M$ 42.99M$ 51.08M$ 57.13M$ 22.59M
Total Assets$ 38.91M$ 63.92M$ 76.38M$ 81.39M$ 47.29M
Total Debt$ 15.04M$ 11.59M$ 12.32M$ 4.65M$ 7.68M
Net Debt$ 4.60M$ 7.34M$ 1.74M$ -8.34M$ -9.15M
Total Liabilities$ 25.45M$ 50.70M$ 25.54M$ 13.30M$ 25.26M
Stockholders' Equity$ 13.46M$ 13.22M$ 50.84M$ 68.09M$ 22.03M
Cash Flow
Free Cash Flow$ -43.93M$ -22.91M$ -26.56M$ -23.67M$ -23.21M
Operating Cash Flow$ -43.87M$ -22.61M$ -26.24M$ -23.57M$ -23.21M
Investing Cash Flow$ 29.37M$ 1.44M$ 4.01M$ -38.22M$ 16.67M
Financing Cash Flow$ 20.66M$ 15.06M$ 20.44M$ 57.75M$ 17.87M
Currency in USD

Bioline Rx Earnings and Revenue History

Bioline Rx Debt to Assets

Bioline Rx Cash Flow

Bioline Rx Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis